Search Results - "Uttenthal, Benjamin J."
-
1
Managing relapsed refractory lymphoma with palliative oral chemotherapy: A multicentre retrospective study
Published in EJHaem (01-11-2022)“…PEP‐C (prednisolone, etoposide, procarbazine and cyclophosphamide) is an orally administered daily chemotherapy regimen used with palliative intent in relapsed…”
Get full text
Journal Article -
2
Incidence and outcomes of post‐transplant lymphoproliferative disease after 5365 solid‐organ transplants over a 20‐year period at two UK transplant centres
Published in British journal of haematology (01-05-2022)“…Summary Post‐transplant lymphoproliferative disease (PTLD) is a life‐threatening complication of solid‐organ transplantation (SOT). We present the incidence…”
Get full text
Journal Article -
3
Guideline for the first‐line management of Classical Hodgkin Lymphoma — A British Society for Haematology guideline
Published in British journal of haematology (01-06-2022)“…Summary This guideline was compiled according to the British Society for Haematology (BSH) process at BSH Guidelines Process 2016 (b‐s‐h.org.uk). The Grading…”
Get full text
Journal Article -
4
Advanced Hodgkin lymphoma in the East of England: a 10-year comparative analysis of outcomes for real-world patients treated with ABVD or escalated-BEACOPP, aged less than 60 years, compared with 5-year extended follow-up from the RATHL trial
Published in Annals of hematology (01-04-2021)“…Treatment with ABVD (doxorubicin, bleomycin, vinblastine, and dacarbazine) or escalated(e)-BEACOPP (bleomycin, etoposide, doxorubicin, cyclophosphamide,…”
Get full text
Journal Article -
5
Challenges in T cell receptor gene therapy
Published in The journal of gene medicine (01-06-2012)“…The function of T lymphocytes as orchestrators and effectors of the adaptive immune response is directed by the specificity of their T cell receptors (TCRs)…”
Get full text
Journal Article -
6
The Wolf at the Door
Published in The New England journal of medicine (07-06-2012)“…A 29-year-old man presented with a 1-week history of fever, night sweats, reduced appetite, and left upper abdominal pain exacerbated by inspiration. He…”
Get full text
Journal Article -
7
P015: Real World Escalated BEACOPDac Delivers Similar Outcomes to Escalated BEACOPP While Potentially Reducing Haematopoietic and Reproductive Toxicity
Published in HemaSphere (03-10-2022)Get full text
Journal Article -
8
Incidence and Outcomes of Post-Transplant Lymphoproliferative Disease after 5365 Solid Organ Transplants over a 20 Year Period at 2 UK Transplant Centres
Published in Blood (23-11-2021)“…Background: Post-transplant lymphoproliferative disease (PTLD) confers a high morbidity and mortality in a vulnerable population. We present the epidemiology…”
Get full text
Journal Article -
9
-
10
Real World Escalated Beacopdac Delivers Similar Outcomes to Escalated Beacopp and Superior Outcomes to Response-Adapted (RATHL) ABVD, While Potentially Reducing Toxicity Compared with Escalated Beacopp
Published in Blood (23-11-2021)“…▪ Background: In the treatment of advanced Hodgkin lymphoma, it is increasingly common UK practice to modify escalated BEACOPP (eBPP) by removing oral…”
Get full text
Journal Article -
11
The Cambridge University Hospitals and Anglia Regional Experience of Using PEP-C As Palliative Chemotherapy in Lymphoma
Published in Blood (08-12-2017)“…PEP-C (prednisolone, etoposide, procarbazine, and cyclophosphamide) is an orally administered chemotherapy regimen used with palliative intent in relapsed or…”
Get full text
Journal Article -
12
Procarbazine-Free Escalated Beacopdac in Frontline Therapy of Advanced Hodgkin Lymphoma Reduces Red Cell Transfusion Requirements and May Shorten Time to Menstrual Period Recovery Compared to Escalated Beacopp and Appears to be As Efficacious
Published in Blood (13-11-2019)“…Introduction Since interim results from the EuroNet-PHL-C1 study1were published in 2013 showing that the gonadotoxic drug procarbazine in COPP can be safely…”
Get full text
Journal Article -
13
Advanced-Stage Hodgkin Lymphoma in the East of England Cancer Network: A 10-Year Comparative Analysis of Outcomes for Patients Treated with ABVD or Escalated BEACOPP in the Non-Trial Setting Compared with Age-Matched Patients Treated in the Multinational RATHL Trial
Published in Blood (08-12-2017)“…Introduction: The majority of young patients presenting with advanced-stage Hodgkin lymphoma (HL) in the UK are managed with ABVD. However, from 2009,…”
Get full text
Journal Article -
14
Endogenous T Cell Receptors Drive Non-Specific Suppression by Foxp3 MHC Class I-Restricted T Cell Receptor-Transduced Polyclonal CD4+ T Cells in Models of Graft-Versus-Host Disease
Published in Blood (16-11-2012)“…Abstract 3152 Alloreactive immune responses directed against malignant cells in recipients of allogeneic hematopoietic stem cell transplants are able to cure…”
Get full text
Journal Article -
15
Clinical problem-solving. The wolf at the door
Published in The New England journal of medicine (07-06-2012)Get full text
Journal Article